SC
CDMO

Steven Cohen’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Steven Cohen’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,815,806
Closed -$43.4M – 2559
2024
Q3 		$43.4M Buy
3,815,806
+1,142,756
+43% +$11.5M 0.11% 213
2024
Q2 		$19.1M Buy
2,673,050
+904,733
+51% +$6.92M 0.05% 413
2024
Q1 		$11.8M Buy
1,768,317
+1,258,486
+247% +$8.66M 0.03% 653
2023
Q4 		$3.31M Buy
509,831
+314,757
+161% +$2.03M 0.01% 1059
2023
Q3 		$1.84M Buy
+195,074
New +$2.35M 0.01% 1155
2022
Q4 		– Sell
-480,490
Closed -$9.19M – 1853
2022
Q3 		$9.19M Buy
480,490
+351,890
+274% +$6.41M 0.04% 529
2022
Q2 		$1.96M Sell
128,600
-182,639
-59% -$2.7M 0.01% 942
2022
Q1 		$6.34M Buy
+311,239
New +$6.34M 0.03% 637
2021
Q4 		– Sell
-308,780
Closed -$6.66M – 1348
2021
Q3 		$6.66M Buy
308,780
+21,480
+7% +$519K 0.03% 598
2021
Q2 		$7.37M Buy
+287,300
New +$6.14M 0.03% 522
2021
Q1 		– Sell
-89,563
Closed -$1.03M – 1220
2020
Q4 		$1.03M Buy
+89,563
New +$819K 0.01% 805

Other funds holding CDMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.39B AUM 53.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Steven Cohen's CDMO Position: Q4 2024 in Review

Steven Cohen sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2024, closing a stake of 3,815,806 shares — an estimated $43.4M sold.

Steven Cohen first reported a position in CDMO in Q4 2020 and held it in 11 quarters. The position peaked at $43.4M in Q3 2024. 195 funds tracked by Wall St. Rank hold CDMO as of Q4 2024.

  • Steven Cohen reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Steven Cohen sold 3,815,806 Avid Bioservices, Inc. Common Stock shares in Q4 2024, an estimated $43.4M.
  • Steven Cohen first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2020 and held it in 11 quarters.
  • Steven Cohen's Avid Bioservices, Inc. Common Stock position peaked at $43.4M in Q3 2024.
  • 195 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2024.

Based on Point72 Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.